BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ziring D, Wei B, Velazquez P, Schrage M, Buckley NE, Braun J. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics 2006;58:714-25. [DOI: 10.1007/s00251-006-0138-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Gurwitz D. Cancer therapeutics: reflections on natural killer cells. Drug Dev Res 2008;69:285-8. [DOI: 10.1002/ddr.20260] [Reference Citation Analysis]
2 Morris G, Walder K, Berk M, Carvalho AF, Marx W, Bortolasci CC, Yung AR, Puri BK, Maes M. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2022;114:110481. [PMID: 34826557 DOI: 10.1016/j.pnpbp.2021.110481] [Reference Citation Analysis]
3 Zogopoulos P, Vasileiou I, Patsouris E, Theocharis S. The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects: Endocannabinoids and neurotoxicity. J Appl Toxicol 2013;33:246-64. [DOI: 10.1002/jat.2828] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
4 Gruber T, Robatel S, Kremenovic M, Bäriswyl L, Gertsch J, Schenk M. Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma. Cancers (Basel) 2021;13:1934. [PMID: 33923757 DOI: 10.3390/cancers13081934] [Reference Citation Analysis]
5 Avraham Y, Amer J, Doron S, Abu-tair L, Mahamid M, Khatib A, Berry EM, Safadi R. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G1364-72. [DOI: 10.1152/ajpgi.00191.2011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
6 Fulmer ML, Thewke DP. The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2. Cardiovasc Hematol Disord Drug Targets 2018;18:34-51. [PMID: 29412125 DOI: 10.2174/1871529X18666180206161457] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
7 Gordon AJ, Conley JW, Gordon JM. Medical Consequences of Marijuana Use: A Review of Current Literature. Curr Psychiatry Rep 2013;15. [DOI: 10.1007/s11920-013-0419-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
8 Ashton JC, Glass M. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 2007;5:73-80. [PMID: 18615177 DOI: 10.2174/157015907780866884] [Cited by in Crossref: 185] [Cited by in F6Publishing: 180] [Article Influence: 15.4] [Reference Citation Analysis]
9 Tanasescu R, Constantinescu CS. Cannabinoids and the immune system: an overview. Immunobiology 2010;215:588-97. [PMID: 20153077 DOI: 10.1016/j.imbio.2009.12.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 122] [Article Influence: 11.6] [Reference Citation Analysis]
10 Brown AJ. Novel cannabinoid receptors. Br J Pharmacol. 2007;152:567-575. [PMID: 17906678 DOI: 10.1038/sj.bjp.0707481] [Cited by in Crossref: 248] [Cited by in F6Publishing: 248] [Article Influence: 16.5] [Reference Citation Analysis]
11 Basu S, Ray A, Dittel BN. Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens. PLoS One 2013;8:e67587. [PMID: 23826323 DOI: 10.1371/journal.pone.0067587] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
12 Pryimak N, Zaiachuk M, Kovalchuk O, Kovalchuk I. The Potential Use of Cannabis in Tissue Fibrosis. Front Cell Dev Biol 2021;9:715380. [PMID: 34708034 DOI: 10.3389/fcell.2021.715380] [Reference Citation Analysis]
13 Newton CA, Chou PJ, Perkins I, Klein TW. CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J Neuroimmune Pharmacol 2009;4:92-102. [PMID: 18792785 DOI: 10.1007/s11481-008-9126-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
14 Tambaro S, Casu MA, Mastinu A, Lazzari P. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. Eur J Pharmacol 2014;729:67-74. [PMID: 24561047 DOI: 10.1016/j.ejphar.2014.02.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
15 Jayarajan S, Meissler JJ, Adler MW, Eisenstein TK. A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo. Front Pharmacol 2022;12:804950. [DOI: 10.3389/fphar.2021.804950] [Reference Citation Analysis]
16 Grill M, Hasenoehrl C, Kienzl M, Kargl J, Schicho R. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. Histochem Cell Biol 2019;151:5-20. [PMID: 30196316 DOI: 10.1007/s00418-018-1719-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
17 Boligan KF, von Gunten S. Innate lymphoid cells in asthma: cannabinoids on the balance. Allergy 2017;72:839-41. [PMID: 28226397 DOI: 10.1111/all.13145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Nicolaou A, Mauro C, Urquhart P, Marelli-Berg F. Polyunsaturated Fatty Acid-derived lipid mediators and T cell function. Front Immunol 2014;5:75. [PMID: 24611066 DOI: 10.3389/fimmu.2014.00075] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
19 Río CD, Millán E, García V, Appendino G, DeMesa J, Muñoz E. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Biochem Pharmacol 2018;157:122-33. [PMID: 30138623 DOI: 10.1016/j.bcp.2018.08.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
20 Cherkasova V, Kovalchuk O, Kovalchuk I. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers (Basel) 2021;13:4353. [PMID: 34503163 DOI: 10.3390/cancers13174353] [Reference Citation Analysis]
21 Suárez-Pinilla P, López-Gil J, Crespo-Facorro B. Immune system: a possible nexus between cannabinoids and psychosis. Brain Behav Immun 2014;40:269-82. [PMID: 24509089 DOI: 10.1016/j.bbi.2014.01.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
22 Liu MW, Su MX, Wang YH, Wei W, Qin LF, Liu X, Tian ML, Qian CY. Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats. BMC Complement Altern Med 2014;14:94. [PMID: 24612782 DOI: 10.1186/1472-6882-14-94] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
23 Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. J Leukoc Biol 2008;84:1574-84. [PMID: 18791168 DOI: 10.1189/jlb.0508282] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
24 Rom S, Persidsky Y. Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013;8:608-20. [PMID: 23471521 DOI: 10.1007/s11481-013-9445-9] [Cited by in Crossref: 138] [Cited by in F6Publishing: 130] [Article Influence: 15.3] [Reference Citation Analysis]
25 Muppidi JR, Arnon TI, Bronevetsky Y, Veerapen N, Tanaka M, Besra GS, Cyster JG. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone. J Exp Med 2011;208:1941-8. [PMID: 21875957 DOI: 10.1084/jem.20111083] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
26 Gasperi V, Evangelista D, Savini I, Del Principe D, Avigliano L, Maccarrone M, Catani MV. Downstream effects of endocannabinoid on blood cells: implications for health and disease. Cell Mol Life Sci 2015;72:3235-52. [DOI: 10.1007/s00018-015-1924-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
27 Han S, Thatte J, Buzard DJ, Jones RM. Therapeutic Utility of Cannabinoid Receptor Type 2 (CB 2 ) Selective Agonists. J Med Chem 2013;56:8224-56. [DOI: 10.1021/jm4005626] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 9.9] [Reference Citation Analysis]
28 Kaufmann I, Schelling G, Eisner C, Richter HP, Krauseneck T, Vogeser M, Hauer D, Campolongo P, Chouker A, Beyer A, Thiel M. Anandamide and neutrophil function in patients with fibromyalgia. Psychoneuroendocrinology 2008;33:676-85. [DOI: 10.1016/j.psyneuen.2008.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
29 Basu S, Ray A, Dittel BN. Cannabinoid receptor 2 is critical for the homing and retention of marginal zone B lineage cells and for efficient T-independent immune responses. J Immunol 2011;187:5720-32. [PMID: 22048769 DOI: 10.4049/jimmunol.1102195] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
30 Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131:959-971. [PMID: 23465663 DOI: 10.1016/j.jaci.2013.01.046] [Cited by in Crossref: 214] [Cited by in F6Publishing: 199] [Article Influence: 23.8] [Reference Citation Analysis]
31 Schmöle AC, Lundt R, Gennequin B, Schrage H, Beins E, Krämer A, Zimmer T, Limmer A, Zimmer A, Otte DM. Expression Analysis of CB2-GFP BAC Transgenic Mice. PLoS One 2015;10:e0138986. [PMID: 26406232 DOI: 10.1371/journal.pone.0138986] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
32 Martins de lima T, Gorjão R, Hatanaka E, Cury-boaventura M, Portioli silva E, Procopio J, Curi R. Mechanisms by which fatty acids regulate leucocyte function. Clinical Science 2007;113:65-77. [DOI: 10.1042/cs20070006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
33 Buckley NE. The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 2008;153:309-18. [PMID: 17965741 DOI: 10.1038/sj.bjp.0707527] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 5.5] [Reference Citation Analysis]
34 Persidsky Y, Ho W, Ramirez SH, Potula R, Abood ME, Unterwald E, Tuma R. HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav Immun 2011;25 Suppl 1:S61-70. [PMID: 21397004 DOI: 10.1016/j.bbi.2011.03.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
35 Wasik AM, Christensson B, Sander B. The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas. Semin Cancer Biol 2011;21:313-21. [PMID: 22024769 DOI: 10.1016/j.semcancer.2011.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
36 Stanzani A, Galiazzo G, Giancola F, Tagliavia C, De Silva M, Pietra M, Fracassi F, Chiocchetti R. Localization of cannabinoid and cannabinoid related receptors in the cat gastrointestinal tract. Histochem Cell Biol 2020;153:339-56. [PMID: 32095931 DOI: 10.1007/s00418-020-01854-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Simkins T, Crawford RB, Goudreau JL, Lookingland KJ, Kaplan BLF. Enhanced Humoral Immunity in Mice Lacking CB1 and CB2 Receptors (Cnr1 −/− /Cnr2 −/− Mice) is not Due to Increased Splenic Noradrenergic Neuronal Activity. J Neuroimmune Pharmacol 2014;9:544-57. [DOI: 10.1007/s11481-014-9549-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Haspula D, Clark MA. Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases. Int J Mol Sci 2020;21:E7693. [PMID: 33080916 DOI: 10.3390/ijms21207693] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
39 Elbaz M, Ahirwar D, Ravi J, Nasser MW, Ganju RK. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer. Oncotarget 2017;8:29668-78. [PMID: 27213582 DOI: 10.18632/oncotarget.9408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
40 Danner E, Hoffmann F, Lee SY, Cordes F, Orban S, Dauber K, Chudziak D, Spohn G, Wiercinska E, Tast B, Karpova D, Bonig H. Modest and nonessential roles of the endocannabinoid system in immature hematopoiesis of mice. Exp Hematol 2019;78:35-45. [PMID: 31562901 DOI: 10.1016/j.exphem.2019.09.022] [Reference Citation Analysis]
41 Turcotte C, Blanchet MR, Laviolette M, Flamand N. The CB2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci 2016;73:4449-70. [PMID: 27402121 DOI: 10.1007/s00018-016-2300-4] [Cited by in Crossref: 184] [Cited by in F6Publishing: 170] [Article Influence: 30.7] [Reference Citation Analysis]
42 Eisenstein TK, Meissler JJ. Effects of Cannabinoids on T-cell Function and Resistance to Infection. J Neuroimmune Pharmacol 2015;10:204-16. [PMID: 25876735 DOI: 10.1007/s11481-015-9603-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
43 Braun M, Khan ZT, Khan MB, Kumar M, Ward A, Achyut BR, Arbab AS, Hess DC, Hoda MN, Baban B, Dhandapani KM, Vaibhav K. Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization. Brain Behav Immun 2018;68:224-37. [PMID: 29079445 DOI: 10.1016/j.bbi.2017.10.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
44 Tanikawa T, Kurohane K, Imai Y. Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice. Microbiol Immunol 2007;51:1013-9. [PMID: 17951991 DOI: 10.1111/j.1348-0421.2007.tb03985.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
45 Zhou L, Zhou S, Yang P, Tian Y, Feng Z, Xie XQ, Liu Y. Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis. Kidney Int 2018;94:756-72. [PMID: 30093080 DOI: 10.1016/j.kint.2018.05.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
46 Malfitano AM, Basu S, Maresz K, Bifulco M, Dittel BN. What we know and do not know about the cannabinoid receptor 2 (CB2). Semin Immunol 2014;26:369-79. [PMID: 24877594 DOI: 10.1016/j.smim.2014.04.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
47 Sharma DS, Paddibhatla I, Raghuwanshi S, Malleswarapu M, Sangeeth A, Kovuru N, Dahariya S, Gautam DK, Pallepati A, Gutti RK. Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders. J Neuroimmunol 2021;353:577501. [PMID: 33571815 DOI: 10.1016/j.jneuroim.2021.577501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Pereira JP, An J, Xu Y, Huang Y, Cyster JG. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol 2009;10:403-11. [PMID: 19252491 DOI: 10.1038/ni.1710] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 11.6] [Reference Citation Analysis]
49 Oyagawa CRM, de la Harpe SM, Saroz Y, Glass M, Vernall AJ, Grimsey NL. Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines. Front Pharmacol 2018;9:1202. [PMID: 30524271 DOI: 10.3389/fphar.2018.01202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
50 Basu S, Dittel BN. Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol Res. 2011;51:26-38. [PMID: 21626285 DOI: 10.1007/s12026-011-8210-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]
51 Elphick MR. BfCBR: a cannabinoid receptor ortholog in the cephalochordate Branchiostoma floridae (Amphioxus). Gene 2007;399:65-71. [PMID: 17553639 DOI: 10.1016/j.gene.2007.04.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
52 Gentili M, Ronchetti S, Ricci E, Di Paola R, Gugliandolo E, Cuzzocrea S, Bereshchenko O, Migliorati G, Riccardi C. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease. Pharmacol Res 2019;141:21-31. [PMID: 30552973 DOI: 10.1016/j.phrs.2018.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
53 Kho DT, Glass M, Graham ES. Is the Cannabinoid CB 2 Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans? Cannabinoid Pharmacology. Elsevier; 2017. pp. 367-96. [DOI: 10.1016/bs.apha.2017.03.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Chiurchiù V, Battistini L, Maccarrone M. Endocannabinoid signalling in innate and adaptive immunity. Immunology 2015;144:352-64. [PMID: 25585882 DOI: 10.1111/imm.12441] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 10.6] [Reference Citation Analysis]
55 Zarruk JG, Fernández-López D, García-Yébenes I, García-Gutiérrez MS, Vivancos J, Nombela F, Torres M, Burguete MC, Manzanares J, Lizasoain I, Moro MA. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 2012;43:211-9. [PMID: 22020035 DOI: 10.1161/STROKEAHA.111.631044] [Cited by in Crossref: 132] [Cited by in F6Publishing: 77] [Article Influence: 12.0] [Reference Citation Analysis]
56 Giuffrida A, McMahon LR. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. Prostaglandins Other Lipid Mediat 2010;91:90-103. [PMID: 19523530 DOI: 10.1016/j.prostaglandins.2009.05.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
57 Yuan CY, Zhou V, Sauber G, Stollenwerk T, Komorowski R, López A, Tolón RM, Romero J, Hillard CJ, Drobyski WR. Signaling through the type 2 cannabinoid receptor regulates the severity of acute and chronic graft-versus-host disease. Blood 2021;137:1241-55. [PMID: 33027805 DOI: 10.1182/blood.2020004871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol. 2008;153:263-270. [PMID: 17906675 DOI: 10.1038/sj.bjp.0707486] [Cited by in Crossref: 157] [Cited by in F6Publishing: 148] [Article Influence: 10.5] [Reference Citation Analysis]
59 Innocenzi E, De Domenico E, Ciccarone F, Zampieri M, Rossi G, Cicconi R, Bernardini R, Mattei M, Grimaldi P. Paternal activation of CB2 cannabinoid receptor impairs placental and embryonic growth via an epigenetic mechanism. Sci Rep 2019;9:17034. [PMID: 31745152 DOI: 10.1038/s41598-019-53579-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
60 Hwang IY, Boularan C, Harrison K, Kehrl JH. Gαi Signaling Promotes Marginal Zone B Cell Development by Enabling Transitional B Cell ADAM10 Expression. Front Immunol 2018;9:687. [PMID: 29696016 DOI: 10.3389/fimmu.2018.00687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]